Biocon Biologics recognized as Asia IP Elite for 2024 by IAM Ruchika Sharma12 Dec 2024 12:39 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Limited, has announced that it has once again been recognized as an Asia IP Elite for...
Biocon gets EIR with VAI status from USFDA for Bengaluru API facility Ruchika Sharma9 Dec 2024 11:30 AM ISTBangalore: In a recent BSE filing, Biocon has informed that the U.S. Food and Drug Administration (US FDA) has issued an Establishment...
USFDA classifies Biocon Biologics Biocon Park Site in Bengaluru as VAI Ruchika Sharma11 Nov 2024 11:33 AM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' facilities at Biocon Park,...
Biocon Biologics Bengaluru drug substance facility classified as VAI Ruchika Sharma4 Nov 2024 12:30 PM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' Drug Substance Facility at Biocon...
Biocon gets 4 USFDA observations for Bengaluru facility Ruchika Sharma30 Sept 2024 6:45 PM ISTBangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection with four...
Biocon partners with Tabuk Pharma to commercialize GLP -1 products in Middle East region Ruchika Sharma27 Sept 2024 11:30 AM ISTBengaluru: Biocon Limited, a global biopharmaceutical company, has announced the signing of a licensing and supply agreement with Tabuk...
USFDA concludes inspection at Biocon Bengaluru API facility Ruchika Sharma23 Sept 2024 12:06 PM ISTBangalore: Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded a surveillance inspection at the Company's...
Biocon arm gets USFDA nod for chronic heart failure drug Sacubitril/Valsartan Ruchika Sharma2 Sept 2024 11:27 AM ISTBangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval of its...
Biocon gets USFDA EIR for Visakhapatnam API facility Ruchika Sharma6 Aug 2024 11:33 AM ISTBangalore: Biocon has announced that the Company has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated...
USFDA concludes inspection at Biocon Biologics Bengaluru facilities Ruchika Sharma29 July 2024 12:53 PM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) has concluded a combined cGMP inspection and PreLicensing Inspection (PLI) at...
USFDA inspection: Biocon gets 4 observations for Visakhapatnam API facility Ruchika Sharma24 Jun 2024 2:15 PM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded a GMP inspection of the...
Biocon arm receives EMA approval to manufacture biosimilar Bevacizumab at Bengaluru facility Ruchika Sharma24 Jun 2024 12:15 PM ISTBengaluru: Biocon Biologics Ltd, a global, fully integrated biosimilars company and a subsidiary of Biocon Ltd, has received approval from the...
